Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.
Tan
Victoria P Y
VP
Wong
Benjamin C Y
BC
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage; D000284:Administration, Oral; D044466:Asian People; D004334:Drug Administration Schedule; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000208:ethnology / Q000628:therapy*; D004384:Duodenoscopy; D005773:Gastroscopy; D006489:Hemostatic Techniques; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007262:Infusions, Intravenous; D009853:Omeprazole / Q000008:administration & dosage; D000077402:Pantoprazole; D010438:Peptic Ulcer Hemorrhage / Q000208:ethnology / Q000517:prevention & control / Q000628:therapy*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D064750:Rabeprazole; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy / Q000208:ethnology / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D000077402:Pantoprazole; D009853:Omeprazole